The phosphatase and tensin homologue deleted on chromosome 10 mediates radiosensitivity in head and neck cancer
- PMID: 20502457
- PMCID: PMC2883706
- DOI: 10.1038/sj.bjc.6605707
The phosphatase and tensin homologue deleted on chromosome 10 mediates radiosensitivity in head and neck cancer
Abstract
Background: For locally advanced squamous cell carcinoma of the head and neck (HNSCC), the recurrence rate after surgery and postoperative radiotherapy is between 20 and 40%, and the 5-year overall survival rate is approximately 50%. Presently, no markers exist to accurately predict treatment outcome. Expression of proteins in the human epidermal growth factor receptor (EGFR) pathway has been reported as a prognostic marker in several types of cancer.
Methods: The aim of this study was to investigate the prognostic value of proteins in the EGFR pathway in HNSCC. For this purpose, we collected surgically resected tissue of 140 locally advanced head and neck cancer patients, all treated with surgery and postoperative radiotherapy.
Results: In a multivariate analysis, expression of the phosphatase and tensin homologue deleted on chromosome 10 (PTEN) was significantly related to worse locoregional control (LRC; HR: 2.2, 95% CI: 1.1-4.6; P=0.03), independent of lymph node metastases (HR: 5.6, 95% CI: 1.2-27.4; P=0.03) and extranodal spread (HR: 2.7; 95% CI: 1.2-6.5; P=0.02). In vitro clonogenic radiosensitivity assays confirmed that overexpression of PTEN resulted in increased radioresistance.
Conclusion: Our study is the first report showing that expression of PTEN mediates radiosensitivity in vitro and that increased expression in advanced HNSCC predicts worse LRC.
Figures


Similar articles
-
PTEN as a prognostic and predictive marker in postoperative radiotherapy for squamous cell cancer of the head and neck.PLoS One. 2012;7(3):e33396. doi: 10.1371/journal.pone.0033396. Epub 2012 Mar 7. PLoS One. 2012. PMID: 22413021 Free PMC article. Clinical Trial.
-
c-Met expression is a marker of poor prognosis in patients with locally advanced head and neck squamous cell carcinoma treated with chemoradiation.Int J Radiat Oncol Biol Phys. 2014 Mar 1;88(3):701-7. doi: 10.1016/j.ijrobp.2013.11.013. Int J Radiat Oncol Biol Phys. 2014. PMID: 24521684
-
Survivin and pAkt as potential prognostic markers in squamous cell carcinoma of the head and neck.Oral Surg Oral Med Oral Pathol Oral Radiol. 2014 Jun;117(6):733-42. doi: 10.1016/j.oooo.2014.02.005. Epub 2014 Feb 13. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014. PMID: 24726415
-
Radioresistance in head and neck squamous cell carcinoma: Biological bases and therapeutic implications.Head Neck. 2015 May;37(5):763-70. doi: 10.1002/hed.23837. Epub 2015 Jan 27. Head Neck. 2015. PMID: 24995469 Review.
-
Targeting EGFR-PI3K-AKT-mTOR signaling enhances radiosensitivity in head and neck squamous cell carcinoma.Expert Opin Ther Targets. 2015 Jun;19(6):795-805. doi: 10.1517/14728222.2015.1012157. Epub 2015 Feb 5. Expert Opin Ther Targets. 2015. PMID: 25652792 Review.
Cited by
-
PTEN as a prognostic and predictive marker in postoperative radiotherapy for squamous cell cancer of the head and neck.PLoS One. 2012;7(3):e33396. doi: 10.1371/journal.pone.0033396. Epub 2012 Mar 7. PLoS One. 2012. PMID: 22413021 Free PMC article. Clinical Trial.
-
Low PTEN expression is associated with worse overall survival in head and neck squamous cell carcinoma patients treated with chemotherapy and cetuximab.Int J Clin Oncol. 2015 Apr;20(2):282-9. doi: 10.1007/s10147-014-0707-1. Epub 2014 May 27. Int J Clin Oncol. 2015. PMID: 24858479
-
FGFR Family Members Protein Expression as Prognostic Markers in Oral Cavity and Oropharyngeal Squamous Cell Carcinoma.Mol Diagn Ther. 2016 Aug;20(4):363-74. doi: 10.1007/s40291-016-0204-5. Mol Diagn Ther. 2016. PMID: 27278367 Free PMC article.
-
Stathmin as a surrogate marker of phosphatidylinositol-3-kinase pathway activity: Towards precision medicine in HPV-negative head & neck squamous cell carcinoma.Genes Dis. 2020 Dec 13;9(3):820-825. doi: 10.1016/j.gendis.2020.12.002. eCollection 2022 May. Genes Dis. 2020. PMID: 35782981 Free PMC article.
-
Contribution of mTOR and PTEN to Radioresistance in Sporadic and NF2-Associated Vestibular Schwannomas: A Microarray and Pathway Analysis.Cancers (Basel). 2020 Jan 10;12(1):177. doi: 10.3390/cancers12010177. Cancers (Basel). 2020. PMID: 31936793 Free PMC article.
References
-
- Ang KK, Berkey BA, Tu X, Zhang HZ, Katz R, Hammond EH, Fu KK, Milas L (2002) Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res 62(24): 7350–7356 - PubMed
-
- Cairns P, Okami K, Halachmi S, Halachmi N, Esteller M, Herman JG, Jen J, Isaacs WB, Bova GS, Sidransky D (1997) Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res 57(22): 4997–5000 - PubMed
-
- Camp RL, Charette LA, Rimm DL (2000) Validation of tissue microarray technology in breast carcinoma. Lab Invest 80(12): 1943–1949 - PubMed
-
- Chung CH, Ely K, McGavran L, Varella-Garcia M, Parker J, Parker N, Jarrett C, Carter J, Murphy BA, Netterville J, Burkey BB, Sinard R, Cmelak A, Levy S, Yarbrough WG, Slebos RJ, Hirsch FR (2006) Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas. J Clin Oncol 24(25): 4170–4176 - PubMed
-
- Chung CH, Gillison ML (2009) Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications. Clin Cancer Res 15(22): 6758–6762 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous